MEDSF Access to medicines https://www.medsf.org/rss/access-medicines en Report: Deadly Gaps https://www.medsf.org/report-deadly-gaps MEDSF released a report covering the challenges that the worldwide response to malaria, HIV, and tuberculosis may face if the Global Fund's upcoming replenishment conference is insufficient. Thu, 15 May 2025 15:30:11 +0000 9edeb647-e659-49de-814f-6348f1a771d7 MEDSF strengthening commitment to access to products for healthcare https://www.medsf.org/msf-strengthening-commitment-access-products-healthcare MEDSF is implementing a new structure starting January 2025 on access to healthcare products. Tue, 25 Jun 2024 11:41:14 +0000 ce9dac55-19e7-4e07-a5f0-83bd136739da Syrians suffer from more funding cuts despite severe medical needs https://www.medsf.org/syrians-suffer-more-funding-cuts-despite-severe-medical-needs Ahead of international donors and donor states meeting in Brussels on 27 May, MEDSF calls for the prioritisation of financial support for the Syrian health sector. Fri, 24 May 2024 09:03:18 +0000 bbf1250b-411b-4b94-afa3-c31fbfcf2123 MEDSF reveals cost of landmark TB clinical trial in push for drug-development cost transparency https://www.medsf.org/msf-reveals-cost-landmark-tb-clinical-trial-push-drug-development-cost-transparency MEDSF reveals the cost of landmark TB clinical trial, urging transparency in clinical trial costs to foster equitable access to medical products worldwide. Thu, 25 Apr 2024 12:24:18 +0000 62c1d0c7-82bd-414e-a3a0-ca86dda56f9e Urgent measures needed to address gaps in Universal Health Coverage targets https://www.medsf.org/urgent-measures-needed-address-gaps-universal-health-coverage-targets Ahead of the UN High Level meeting on Universal Health Coverage on 21 September, this report highlights why access to healthcare continues to be challenging for people in vulnerable circumstances. Wed, 13 Sep 2023 07:15:09 +0000 afd60d54-c5a0-48fc-83b1-7f6295ebc33b Universal Health Coverage targets leave behind the most vulnerable https://www.medsf.org/universal-health-coverage-targets-leave-behind-most-vulnerable Ahead of the UN High Level meeting on Universal Health Coverage on 21 September, we examine why access to healthcare continues to be challenging for people in vulnerable circumstances. Wed, 13 Sep 2023 06:16:29 +0000 6bd8390e-e17a-48be-a20d-f50d8151eebd Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests https://www.medsf.org/johnson-johnson-and-cepheid-must-pledge-access-lifesaving-tb-medicines-and-tests Ahead of the global tuberculosis High-Level Meeting at the United Nations, Johnson & Johnson and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need. Tue, 12 Sep 2023 07:34:43 +0000 d9c472b8-eed4-4c1b-b69d-5b36fd38e12c MEDSF statement on pandemic prevention, preparedness and response https://www.medsf.org/msf-statement-pandemic-prevention-preparedness-and-response Read MEDSF's statement delivered to the WHO's intergovermental negotiating body meeting on pandemic prevention, preparedness and response. Tue, 28 Feb 2023 11:32:18 +0000 4086047f-9805-42c9-9bc8-1500c5cce193 Lack of a real IP waiver on COVID-19 tools is a disappointing failure for people https://www.medsf.org/lack-real-ip-waiver-covid-19-tools-disappointing-failure-people After more than 20 months of negotiations, countries at the World Trade Organization have reached an agreement on an intellectual property waiver for COVID-19 vaccines and drugs that falls short of hopes for a good deal. Fri, 17 Jun 2022 11:56:24 +0000 fe97effc-f836-4ed8-bc76-8f5e2b17570d Drug-resistant tuberculosis trial results in updated treatment guidelines https://www.medsf.org/drug-resistant-tuberculosis-trial-results-updated-treatment-guidelines WHO has announced it will update treatment guidelines for multidrug-resistant TB, following strong results of MEDSF's TB PRACTECAL trial. But the price of the new regimens must come down. Wed, 04 May 2022 10:56:12 +0000 15478466-aeab-4896-86e9-b927f98ac89f